Williamson Robert F III
Insider CIK 1397331 · VRUS Director · ISR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics, | A Award deriv | 2026-03-02 | 2026-03-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2025-11-12 | 2025-11-14 | 9,498 | $2.10 | $19.9K | 9,864 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2025-03-31 | 2025-04-01 | 38,145 | $2.14 | $81.6K | 108,982 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2025-03-28 | 2025-04-01 | 22,192 | $2.27 | $50.4K | 70,837 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2025-03-03 | 2025-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-11-25 | 2024-11-27 | 2,619 | $3.67 | $9.6K | 430,058 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-11-25 | 2024-11-27 | 3,647 | $3.62 | $13.2K | 427,439 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2024-06-20 | 2024-06-24 | 23,000 | — | $0 | 23,000 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-05-31 | 2024-06-03 | 55,000 | $1.38 | $75.9K | 423,792 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-05-29 | 2024-05-30 | 18,656 | $1.34 | $25.0K | 368,792 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-05-29 | 2024-05-30 | 11,375 | $1.32 | $15.0K | 350,136 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-30 | 2024-02-01 | 3,500 | $0.70 | $2.5K | 338,761 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-30 | 2024-02-01 | 18,579 | $0.71 | $13.2K | 230,134 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-30 | 2024-02-01 | 5,127 | $0.71 | $3.6K | 235,261 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-30 | 2024-02-01 | 57,121 | $0.71 | $40.6K | 292,382 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-30 | 2024-02-01 | 42,879 | $0.72 | $30.9K | 335,261 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-29 | 2024-01-30 | 4,031 | $0.64 | $2.6K | 190,320 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-29 | 2024-01-30 | 21,235 | $0.64 | $13.6K | 211,555 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-26 | 2024-01-30 | 14,850 | $0.61 | $9.1K | 102,776 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-26 | 2024-01-30 | 12,250 | $0.61 | $7.5K | 87,926 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-26 | 2024-01-30 | 50,000 | $0.54 | $27.0K | 186,289 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-26 | 2024-01-30 | 25,000 | $0.55 | $13.8K | 136,289 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-26 | 2024-01-30 | 8,513 | $0.59 | $5.0K | 111,289 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-25 | 2024-01-26 | 22,134 | $0.49 | $10.8K | 75,676 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-01-24 | 2024-01-26 | 29,862 | $0.49 | $14.6K | 53,542 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2023-12-21 | 2023-12-26 | 3,663 | $0.33 | $1.2K | 3,663 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2023-12-19 | 2023-12-19 | 13,680 | $0.32 | $4.4K | 23,680 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2023-12-18 | 2023-12-19 | 10,000 | $0.26 | $2.6K | 10,000 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2023-12-12 | 2023-12-14 | 230,000 | — | $0 | 930,000 | SEC↗ |
| ISR Perspective Therapeutics, | A Award deriv | 2023-02-21 | 2023-03-17 | 470,000 | — | $0 | 470,000 | SEC↗ |
| ISR Perspective Therapeutics, | A Award deriv | 2023-02-21 | 2023-03-17 | 230,000 | — | $0 | 700,000 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 13,333 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 16,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 13,333 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 20,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 20,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 40,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 40,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 40,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 15,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | U Tender | 2012-01-12 | 2012-01-17 | 7,000 | $137.00 | $959.0K | 0 | SEC↗ |